News

Para-site-seeing Catalogue

Floyd, A, Yeoman, H, Southern, J, Dillon, R, Cook, S, Fairlamb, A, Ferguson, M, Horn, D, MacLean, L, Manthri, S,..

Read More
Joana Faria

Joana Faria wins the SULSA ECR Prize

At the end of March we announced Joana Faria had been shortlisted for the SULSA Early Career Research award in..

Read More
A young woman gazes at computer screens showing red and green scientific data

Julia Wcislo Shortlisted for 2020 Max Perutz Science Writing Award

An article by Julia Wcislo is one of the ten outstanding articles that have been shortlisted for the 2020 Max..

Read More
A watercolour of scientist Alan Fairlamb and artist Emily Fong as they share mobile phones, over an online meeting

New artist blog post

We're excited to announce another new piece of work from the wonderful Emily Fong. Our artist-in-remote-residence has been taking a..

Read More
Mode of Action group logo. it reads 'Novel biology to novel medicines. Fighting Neglected Diseases'

Mode of Action group awarded £4.9million from Wellcome

The Mode of Action group within the Wellcome Centre for Anti-Infectives Research (WCAIR),University of Dundee, have been awarded £4.9million in..

Read More

WCAIR joins CARE

The Universities of Dundee and Edinburgh are playing key roles in a €77.7 million pan-European consortium seeking to accelerate the..

Read More

Science@Home with Dundee Science Centre

There have been lots of changes during the Covid-19 pandemic. One thing that has remained the same is how busy..

Read More

€5 million boost for coronavirus drug search

The Dundee Drug Discovery Unit (DDU), embedded with WCAIR,  has received €5 million of funding to develop antiviral treatments for..

Read More
The Hamilton machine at The Drug Discovery Unit at The University of Dundee © Sophie Gerrard

New Funding to find COVID-19 treatments

The Universities of Glasgow and Dundee have been awarded £225,000 to rapidly screen for potential COVID-19 treatments. The project is..

Read More
artist impression of the DDU malaria pre-clinical candidate

Anti-malarial candidate progresses through first in human studies

Back in October 2013 Medicines for Malaria Venture (MMV) selected a compound designed and developed at the Drug Discovery Unit..

Read More